Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « intravenous »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
intraveneous < intravenous < intravenously  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000008 (2010) P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]Tocilizumab
000021 (2010) Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000022 (2011) Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000025 (2014) Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
000027 (2010) Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000055 (2012) Metin I K [Turquie] ; Levent K L Ç [Turquie] ; Smail Do An [Turquie] ; Meral Çalgüneri [Turquie]Tocilizumab for giant cell arteritis: an amazing result
000211 (2006) Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]Biologic therapies for inflammatory eye disease
000496 (2013) S. Valiyeva [Russie] ; E. Alexeeva [Russie] ; T. Bzarova [Russie] ; R. Denisova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie]THU0303 The efficacy and safety of ibandronic acid for intravenous administration for treatment of severe systemic osteoporosis in patients with juvenile arthritis
000503 (2013) M. E. Weinblatt [États-Unis] ; M. C. Genovese ; M. H. Schiff [États-Unis] ; R. Westhovens [Belgique] ; R. Alten [Allemagne] ; I. Delaet [Belgique] ; M. Nys ; J. Manning [Belgique] ; J. M. Kremer [États-Unis]FRI0191 Immunogenicity is low and transient with intravenous abatacept therapy
000512 (2010) Aharon Kessel [Israël] ; Regina Peri [Israël] ; Tharwat Haj [Israël] ; Ayelet Snir [Israël] ; Gleb Slobodin [Israël] ; Edmond Sabo [Israël] ; Itzhak Rosner [Israël] ; Yehuda Shoenfeld [Israël] ; Elias Toubi [Israël]IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
000530 (2011) Dimitrios Christidis [Royaume-Uni] ; Shaifali Jain [Royaume-Uni] ; Bhaskar Das Gupta [Royaume-Uni]Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement
000584 (2012) Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis]Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
000604 (2013) M. Hochberg [États-Unis] ; S. Berry [États-Unis] ; K. Broglio [États-Unis] ; A. Nadkarni [États-Unis] ; L. Rosenblatt [États-Unis] ; D. Trivedi [États-Unis] ; T. Hebden [États-Unis]AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs
000654 (2013) U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
000679 (2013) M. Schiff [États-Unis] ; R. Alten [Allemagne] ; M. Weinblatt [États-Unis] ; P. Nash [Australie] ; R. Fleischmann [États-Unis] ; P. Durez [Belgique] ; J. Kaine ; I. Delaet ; S. Kelly ; M. Maldonado ; S. Patel ; M. Genovese [États-Unis]AB0323 Weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without an intravenous abatacept loading dose
000702 (2013) A. Ogata [Japon]FRI0180 The musashi study: Comparison of subcutaneous tocilizumab monotherapy versus intravenous tocilizumab monotherapy: Results from a double-blind, parallel-group, comparative phase III non-inferiority study in japanese patients with rheumatoid arthritis
000920 (2012) Laine H. Koch [États-Unis] ; Christle J. Layton [États-Unis] ; Monika Pilichowska [États-Unis] ; Miguel J. Stadecker [États-Unis] ; Orr Barak [États-Unis]Paraneoplastic Pemphigus and Castleman’s Disease in the Setting of Herpes Simplex Virus Infection
000999 (2013) M. Harigai ; S. Inokuma [Japon] ; N. Ishiguro ; J. Ryu ; T. Takeuchi [Japon] ; S. Takei ; Y. Tanaka ; H. Yamanaka ; Y. Sano [Japon] ; H. Yaguramaki [Japon] ; T. Koike [Japon]SAT0120 Characteristics Associated with Better Effectiveness and Safety in Rheumatoid Arthritis Patients Treated with Intravenous Tocilizumab: Results from Full Analysis of All-Patient Postmarketing Surveillance in Japan
000C76 (2011) P. Willeke [Allemagne] ; H. Becker [Allemagne] ; S. Wassenberg [Allemagne] ; H. Pavenst Dt [Allemagne] ; A. M. Jacobi [Allemagne]Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen
000E49 (2012) Ho-Chang Kuo [République populaire de Chine] ; Ya-Ling Yang [République populaire de Chine] ; Jiin-Haur Chuang [République populaire de Chine] ; Mao-Meng Tiao [République populaire de Chine] ; Hong-Ren Yu [République populaire de Chine] ; Li-Tung Huang [République populaire de Chine] ; Kuender D. Yang [République populaire de Chine] ; Wei-Chiao Chang [République populaire de Chine] ; Chiu-Ping Lee [République populaire de Chine] ; Ying-Hsien Huang [République populaire de Chine, Taïwan]Inflammation-Induced Hepcidin is Associated with the Development of Anemia and Coronary Artery Lesions in Kawasaki Disease
000E70 (2009) E. Schmidt [Allemagne]Therapieoptimierung bei schweren bullösen Autoimmundermatosen

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "intravenous" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "intravenous" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    intravenous
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021